| 12A-1130808 |
Che-Ming (Jack) Hu |
Charge-discriminating antimicrobial coacervates and uses thereof |
| 12A-1130319 |
Yu-Ru Lee |
Antisense Oligonucleotide (ASO) Reduces Tumorigenesis and Promotes Anti-tumor Immunity |
| 12T-1120928 |
Ruey-Bing Yang |
Anti-SCUBE1 monoclonal antibodies for protein expression detection and quantification |
| 12A-1120828 |
Steve R Roffler, Chun-Hung Lin |
Immunoenzyme for selective cancer therapy |
| 12A-1120721 |
Che-Ming Jack Hu |
Method for rapid label-free plasma membrane protein and vesicle isolation |
| 12T-1120510 |
Jer-Yuarn Wu |
smartEDC : Electronic Data Capture |
| 12A-1120322 |
Che-Ming Jack Hu |
Single-shot universal influenza vaccine |
| 12A-1111215 |
Che-Ming Jack Hu |
Engineered M13 bacteriophage for gene therapy |
| 12A-1110916 |
Yijuang Chern, Yi-Chao Lee, You-Yin Chen, and Jim-Min Fang |
A compound for the treatment of tuberous sclerosis complex |
| 12A-1110630 |
Song-Kun Shyue |
Monoclonal Antibody for Use in Treating Inflammation-related Diseases Modulating Macrophages to M2-like Phenotype to Reduces Inflammation and Injury in Hemorrhagic Stroke, Psoriasis and Sepsis-induced Brain Inflammation (SAE) |
| 12A-1110526 |
Ruey-Bing (Ray) Yang |
Anti-SCUBE1 antibody having high internalization capacity in leukemia |
| 12A-1101001 |
Li, Chia-Wei |
ANTIBODY-DRUG CONJUGATE FOR REDUCING GLYCOSYLATION OF MEMBRANE GLYCOPROTEIN |
| 12A-1100922 |
Yijuang Chern, Chun-Jung Lin, Kuan-Yu Chen and Jim-Min Fang |
METHOD OF TREATING SPINAL CORD INJURY AND COMPOSITION FOR USE THEREIN |
| 12A-1100819 |
Yijuang Chern, Fang-Chia Chang, Jim-Min Fang |
A compound for the treatment of sleep disruptions |
| 12A-1100709 |
Yijuang Chern, Wen-Sung Lai, and Jim-Min Fang |
A compound for the treatment of schizophrenia |
| 12T-1100604 |
Hsieh, Patrick Ching-Ho |
HLA-homozygous iPSCs (THTC-01~THTC-013) |
| 12A-1100219 |
Hsieh, Patrick Ching-Ho |
AAV9-HMGCS2 Delivery for Heart Protection and Regeneration |
| 12A-1091225 |
Dr. Hsieh, Patrick Ching-Ho |
METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION |
| 12T-1090821 |
Tao, Mi-Hua |
Development of COVID-19 ASD25X-RBD recombinant protein vaccine |
| 12A-1090601 |
Pan-Chyr Yang |
ACE2-Fc, decoy antibody blocks SARS-CoV-2 entry and infection |
| 12T-1090520 |
Jer-Yuarn Wu |
iIRB II : IRB Protocols Online Management |
| 12T-1090429 |
Che-Ming Hu |
Nanoparticle vaccine against COVID-19 |
| 12A-1081206 |
Shih-Yu Chen |
Method for natural killer cell expansion using intracellular hydrogelation system |
| 12A-1080808 |
Dr. Hsieh, Patrick Ching-Ho, Research Fellow< IBMS |
Monocyte-Specific Aptamers and Uses Thereof for Delivering Therapeutic Agents to Heart |
| 12A-1080612 |
Dr. Hsieh, Patrick Ching-Ho, |
Monocyte-Specific Aptamers and Uses Thereof for Enhancing Drug Delivery to Cancer |
| 12A-1080506 |
Che-Ming Hu, etc. |
Broadly neutralizing peptide-based nanoparticle influenza vaccine |
| 12A-1080416 |
Che-Ming Hu, etc. |
Method for preparing peptide loaded carrier systems |
| 12T-1080327 |
Yi-Shuian Huang |
CPEB2, CPEB3 and CPEB4 monoclonal antibodies |
| 12A-1080315 |
Shyue, Song-Kun |
Antibody treatment increases M2 microglia and reduces brain injury and inflammatory response after experimental intracerebral hemorrhage |
| 12T-1080314 |
Wen-Harn Pan |
Fatty acid composition and nutrient profile assessment tool |
| 12A-1080214 |
Chen, Chih-Cheng, Hung Chih-Hsien |
METHODS OF TREATMENT AND PREVENTION OF FIBROMYALGIA AND STRESS-RELATED PAIN DISORDERS |
| 12A-1071228 |
Chia-Ho Shih |
Early Diagnosis of Severe EV71 Infection in High-risk Patients |
| 12A-1071106 |
Liao, You-Di |
Prevention of bacterial infection and biofilm formation on medical devices by the coating of antimicrobial peptide with surfactant |
| 12A-1070927 |
Patrick Ching-Ho Hsieh, Tony W.H. Tang, Hung-Chih Chen |
Methods and Compositions To Improve Post Myocardial Infarction Recovery By Restoring Microbiota Balance |
| 12A-1070917 |
Patrick Ching-Ho Hsieh, David Lundy |
Use of VEGF at Multiple Doses to Enhance Permeability of Blood Brain Barrier |
| 12A-1070815 |
Bai Chung Shyu, Andrew Chih Wei Huang |
System for detecting epileptic behaviors using the coil measure magnet-induced voltage changes in magnetic field |
| 12A-1070806 |
Bai Chung Shyu, Arthur Chih-Hsin Tsai, Andrew Chih Wei Huang |
A wireless magnetic resonance device for optogenetic applications in animal model |
| 12A-1070629 |
Liu, Fu-Tong |
The application of metabolic drug in inducing galectin-7 expression in keratinocytes |
| 12A-1070611 |
Che-Ming Hu, etc. |
Colistin nanocomplexes and uses thereof |
| 12A-1070131 |
Pan-Chyr Yang |
A TNF-targeting aptamer with theranostic effects and its applications in TNF-related inflammatory diseases |
| 12A-1061221 |
Che-Ming Jack Hu, Saborni Chattopadhyay |
Pathogenic cell-associating immunologic adjuvants for treatment enhancement |
| 12A-1061103 |
Chih-Cheng Chen、Yu-Chia Chuang |
Biomarkers and methods specific for diagnosis of peripheral neuropathy |
| 12A-1061101 |
Chinpan Chen, Tien-Sheng Tseng, Keng-Chang Tsai |
Inhibitors of bacterial two component signal transduction system and uses thereof |
| 12A-1060929 |
Yuh-Shan Jou |
Phosphorylation of Y523 residue of PSPC1 is a biomarker for cancer progression and therapeutic intervention |
| 12A-1060912 |
Te-Chang Lee |
Novel antitumor compounds with anti-angiogenesis and DNA bifunctional alkylation -- synthetic methods and their use as cancer therapeutic agents |
| 12A-1060522 |
Steve Roffler, Yu-Cheng Su |
Conditional internalization of PEGylated nanoparticles by using Anti-PEG bispecific antibodies |
| 12A-1060111 |
Patrick CH Hsieh, David J. Lundy, Christopher Yu Tai Yen |
Optimization of reloadable hydrogel system for treating glioblastoma |
| 12A-1060110 |
Patrick CH Hsieh, David J. Lundy, Christopher Yu Tai Yen |
Optimization of reloadable hydrogel system for treating myocardial infarction |
| 12A-1050930 |
Pan-Chyr Yang、S.-Ja Tseng、Zi-Xian Liao |
Remote control of light-triggered virotherapy |
| 12A-1050923 |
Chih-Cheng Chen, Jim-Min Fang, Cheng-Han Lee, Jen-Yao Chang |
Compound with Analgesic Effect for Use in Prevention and Treatment of Pain |
| 12A-1050919 |
Yuh-Shan Jou, Roger Shen |
Dipyridamole for use in treating SLC29A2 nuclear-expressing cancer cells |
| 12A-1050902 |
Patrick CH Hsieh, Desy, S. Lee |
miRNA Cocktail to Induce Maturation of Pluripotent Stem Cells-Derived Cardiomyocytes |
| 12A-1050527 |
Te-Chang Lee, Tsann-Long Su |
Potent BO-1978 used alone or in combination therapy for small cell lung cancers |
| 12A-1050526 |
Patrick CH Hsieh, Chen-Yun Chen, Yu-Che Cheng |
TGFBR3 as a biomarker and diagnostics for acute myocardial infarction |
| 12A-1050421 |
Che-Ming Jack Hu、Hui-Wen Chen、Yuan-I Chen、Chen-Ying Chien、Jung-Chen Lin |
Internal fixation of cells and organisms and uses thereof |
| 12A-1050325 |
Ruey-Bing Yang, Yuh-Charn Lin |
Inhibition of SCUBE2, a novel VEGFR2 co-receptor, suppresses tumor angiogenesis |
| 12A-1050308 |
Che-Ming Jack Hu, Hui-Wen Chen, Bing-Yu Yao |
Thin Shell Polymeric Hollow Nanoparticles and Uses Thereof |
| 12A-1050118 |
Eminy H.Y. Lee, Derek Jui-Cheng Tai, Yen-Chen Liu, Wei-Lun Hsu |
Treatment of neurodevelopment disorders |
| 12A-1050113 |
Cathy Fann, Tien-Chun Chang, Pei-Lung Chen, Wei-Shiung Yang... |
Method for assessing the risk of adverse drug reaction and device thereof |
| 12A-1041110 |
Patrick CH Hsieh、Kuang-Ying Hsueh |
Novel systems for delivering cardiovascular cell therapeutics |
| 12A-1040910 |
Patrick CH Hsieh, Chen-Yun Chen |
Method and kit for making diagnosis of myocardial infarction |
| 12A-1040907 |
Steve Roffler, Pierre-Alain Burnouf |
An esterification/saponification-based method for liposomal loading |
| 12A-1040313 |
Malcolm Moore, Jae-Hung Shieh, Tsann-Long Su, Te-Chang Lee |
A Novel Antitumor Agent for the treatment of leukemias, small cell lung cancers, lymphomas, sarcomas, and others. |
| 12A-1040225 |
Pan-Chyr Yang, Pei-Ying Lin, Bo-Tsang Huang |
PINK1 is a Tumor Suppressor in EGFR-driven Carcinogenesis |
| 12A-1040216 |
Steve Roffler, Huai-Yao Chuang |
Engineered enzyme for enzyme replacement therapy |
| 12T-1040213 |
Erh-Chan Yeh, Wan-Jia Lin, Chung-Kuei Li, Jen-Ping Su, ... |
HiPipe : A Cloud-based High Performance NGS Data Analysis Platform |
| 12A-1040126 |
Pan-Chyr Yang, Wei-Yun Lai, Yi-Chung Chang, Bo-Tsang Huang |
An antagonistic PDL1 aptamer and its applications in cancer therapy |
| 12A-1040125 |
Patrick CH Hsieh, Yuan-Yuan Cheng |
A therapeutic gene cocktail for heart regeneration |
| 12A-1040109 |
Patrick CH Hsieh, Bill Cheng |
Platelet-like proteo-microparticles and method of using such in drug delivery |
| 12T-1031121 |
Konan Peck, Pan-Chyr Yang, Yi-Chung Chang, Wei-Yun Lai |
An all-round platform technology for rapid aptamer identification |
| 12T-1030920 |
Pang-Hsien Tu, Wen-Chuan Shen, Yu-May Lee, Yijuang Chern |
Anti-HTT Antibody |
| 12A-1030801 |
Chiaho Shih, Heng-Li Chen, Pei-Yi Su |
Antimicrobial peptides derived from Hepatitis B virus core protein arginine-rich dormain |
| 12A-1030619 |
Pan-Chyr Yang、Yi-Chung Chang、Wei-Yun Lai |
An antagonistic PD-1 aptamer and its applications in cancer therapy related applications |
| 12A-1030616 |
Pan-Chyr Yang, Konan Peck, Yi-Chung Chang, Bo-Tsang Huang, Shauh-Der Yeh |
Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity |
| 12A-1030317 |
Te-Chang Lee, Tsann-Long Su |
Potent antitumor indolizino[6,7-b]indole derivatives used for combination therapy against cancers |
| 12A-1030310 |
Patrick CH Hsieh、Pei-Jung Wu、Steve Roffler、Bill Cheng |
A reloadable delivery system for systemically administered therapeutics |
| 12T-1030103 |
Wen-Harn Pan |
Dietary fatty acid composition prediction tool |
| 12T-1030101 |
Steve Roffler, Tian-Lu Cheng, Bing-Mae Chen |
Anti-PEG Antibodies |
| 12A-1021120 |
Rita P.-Y. Chen, Joseph Jen-Tse Huang, Yijuang Chern |
Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates |
| 12A-1020619 |
Chiaho Shih、Jyun-Yuan Huang |
Cellular microRNAs miR-130a miR-204 and miR-1236 inhibit hepatitis B virus replication |
| 12A-1020605 |
Yuan-Tsong Chen, Jer-Yuan Wu, Tai-Ming Ko, Ho-Chang Kuo, Jeng-Sheng Chang |
Method of diagnosing and treating KAWASAKI disease |
| 12A-1020411 |
Fu-Tong Liu, Wei-Chen Hsieh, Ri-Yao Yang |
Reducing galectin-12 activity to influence the cell function of human sebocytes |
| 12T-1020410 |
Sheau-Yann Shieh |
BTG3 antibody |
| 12T-1020306 |
Yuan-Tsong Chen, Yi-Ching Lee |
The identification and evaluation of botanical drugs for treatment of FGFR3 activating mutation related skeletal dysplasias and |
| 12A-1020225、12A-1020910、12A-1020225-B |
Steve Roffler, Tian-Lu Cheng, Yu-Cheng Su, Kuo-Hsiang Chuang, Teresa Tung |
Bi-specific antibodies and uses thereof |
| 12T-1020104 |
Woan-Yuh Tarn |
RBM4 antibody |
| 12A-1020104 |
Cathy SJ Fann, Tien-Chun Chang, Wei-Shiung Yang, ... |
Single-nucleotide polymorphisms for predicting HLA genotypes |
| 12A-1011214 |
Steve Roffler, Yu-Cheng Su |
In situ affinity maturation of antibodies |
| 12A-1011005 |
Yuan-Tsong Chen, Andrew Tai-Ann Cheng, Chien-Hsiun Chen, ... |
Genetic variants predicting lithium prophylaxis treatment response in bipolar disorder |
| 12A-1011004 |
Chiaho Shih, Heng-Li Chen, Pei-Yi Su |
Antimicrobial peptides derived from Hepatitis B virus |
| 12A-1010829 |
Yi-Ling Lin |
Prochlorperazine for treatment of Flavivirus infection |
| 12A-1010305 |
Hsiu-Ming Shih, Wei-Chih Yang |
USP37 Inactivation as a treatment for PLZF/RARA- associated acute promyelocytic leukemia |
| 12A-1010110 |
Tai-Huang Huang, Ching-Yu Chou, Minglee Chu, Chi-Fon Chang |
High speed sample transportation apparatus in a superconducting magnet and transporting method thereof |
| 12T-1010104 |
Hsueh-Fen Chen, Kuei-Yao Yen, Yi-Chen Chen, Elin Wang,... |
Samportal : Specimen tracking and management system |
| 12T-1010103 |
Pin-Pin Yu, Chi-Chun Huang, Vincent Kao, Wen-Ming Hu, Robert Lin |
iQuestion: Electronic data capture software for clinical research |
| 12A-1001018 |
Yuh-Shan Jou, Chia-Yuan Chang |
Novel LMCD1 mutations promoted tumor cell migration and metastasis in human cancers |
| 12A-1000516 |
Tsann-Long Su ,Te-Chang Lee ,Ting-Chao Chou |
Synthesis of 4H-benzo[d]pyrrolo[1,2-a]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic a |
| 12T-1000127 |
Yuan-Tsong Chen, Jer-Yuarn Wu, Wen-hsuang Yao, ... |
Software: VarioWatch |
| 12A-990402 |
Yuh-Shan Jou, Yi-Wei Wang |
Phosphorylation and mutations of Anaplasitc Lymphoma Kinase as a diagnostic and therapeutic target in lung cancer |
| 12A-990315 |
Wen-Harn Pan, Chia-Min Chung, Jaw-Wen Chen |
Gene polymorphic markers for predicting angiotensin converting enzyme (ACE) activity, risk of strokes, and blood pressure responsivenss to ACE inhibitors |
| 12A-981111 |
Mi-Hua Tao, Cheng-Chieh Fang, Ya-Hui Huang |
A non-human animal disease model for hepatitis B virus-assoicated disease |
| 12A-981008 |
Steve R Roffler, Yu-Lin Leu, Zeljko M Prijovich |
BQC-G, a tumor-selective anti-cancer prodrug |
| 12A-980915 |
Te-Chang Lee, Tsann-Long Su |
Method of Treating Cancer using Combination of a Bifunctional Alkylating Agent and DNA Repair Inhibitors |
| 12A-980722 |
Wen-Harn Pan, Wei-Jei Lee, Hsin-Hung Chen |
Novel ESR1 and PPARγ gene polymorphic markers for obesity |
| 12A-970630 |
Steve Roffler, Chia-Hung Wu, Wolfgang Schechinger |
Human Beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such |
| 12A-970429 |
Chen Chang, Chien-Yuan Lin, Jyh-Horng Chen |
3D Microscopic magnetic resonance angiography |
| 12A-960809 |
Tsann-Long Su, Ting-Chao Chou |
Synthesis of 8H-3a-Aza-cyclopenta[a]indenes and 5,10-Dihydropyrrolo[1,2-b]isoquinolines Derivatives and Their Use as Antitumor Therapeutic Agents |
| 12A-951019、12A-951019B |
Tsann-Long Su, Ting-Chao Chou |
Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents |
| 12A-950206、12A-950206B |
Yuan-Tsong Chen, Wen-Hung Chung, Shuen-Iu Hung |
Granulysin and uses thereof |
| 12A-950101、12A-950101B |
Chih-Cheng Chen, Shyh-Jer Huang, Yi-Wen Lin |
Treatment of insulin resistance |
| 12A-941017、12A-941017B |
Yijuang Chern, Yun-Lian Lin, Nai-Kuei Huang |
Two novel drugs from a Chinese herb for Huntington's disease |
| 12A-931129 |
Yuan-Tsong Chen, Jin-Jer Chen, Hsiang-Yu Yuan |
Genetic variants predicting warfarin sensitivity |
| 12A-930506 |
Wen-Harn Pan, Yuh-Shan Jou, Jaw-Wen Chen, Cathy-S-J Fann |
Risk prediction for hypertension, elevated plasma triglyceride and metabolic syndrome |
| 12A-921112 |
You-Di Liao |
Removal of N-terminal methionine form recombinant proteins by engineered methionine aminopeptidase |
| 12A-921104 |
Yijuang Chern |
Treatment of neurodegenerative diseases |
| 12A-920716、12A-920716B、12A-920716C、12A-920716D |
Yuan-Tsong Chen, Shuen-Iu Hung, Wen-Hung Chung, Jer-Yuarn Wu |
Risk assessment for adverse drug reactions |
| 12A-911101 |
Yijuang Chern, Yi-Chao Lee |
Neurodegenerative disease treatment |
| 12A-900501 |
Mei-Shang Ho, Ya-Ching LIn, Cheng-Nan Wu |
Enterovirus 71: Vaccines and diagnostic reagents |
| 12A-870326 |
Steve Roffler Ji-Wang Chern Ye-Lin Leu |
Proactive antitumor compounds |
| 12A-850802 |
Konan Peck Pah-Chyr Yang Shu-Li Wung |
Methods for rapid antimicrobial susceptibility testing |